yte holds the cleaner structural position, with the lead spread across growth and valuation. On the market side, yte is in better shape — its trend is intact while Vertex Pharmaceuticals's trend has broken down. That puts structure and market broadly in agreement — yte's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
The lead is spread across growth and valuation, rather than sitting in one isolated gap. The overall score gap is 13 points in favour of Incyte Corporation.
Both operate in: Biotechnology
This comparison is based on industry proximity, not on functional trajectory similarity. INCY and VRTX share the same industry classification.
For a similarity-based comparison, see how yte and Vertex Pharmaceuticals each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Incyte Corporation looks stronger both structurally and on relative valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The current lead is backed by a stronger multi-year growth trajectory.
A forward P/E that is 9.1 turns lower adds a second meaningful layer to the lead.
The lead is built on both growth and valuation, making it broader than a single-dimension result.
Break down the INCY vs VRTX comparison across all dimensions with the full interactive tool.
Explore how INCY and VRTX each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.